MRNA
Financials
SEC EDGAR companyfacts, fetched 2026-11-01.
Financials
Tap a column to read the value.
Annual
| Period | Revenue | Gross profit | Operating income | Net income | Free cash flow | Op margin | Net margin |
|---|---|---|---|---|---|---|---|
| 2021 | $18.5B | $15.9B | $13.3B | $12.2B | $13.3B | 72.0% | 66.1% |
| 2022 | $19.3B | $13.8B | $9.4B | $8.4B | $4.6B | 48.9% | 43.4% |
| 2023 | $6.8B | $2.2B | -$4.2B | -$4.7B | -$3.8B | -61.9% | -68.8% |
| 2024 | $3.2B | $1.8B | -$3.9B | -$3.6B | -$4.1B | -121.9% | -110.0% |
| 2025 | $1.9B | $1.1B | -$3.1B | -$2.8B | -$2.1B | -158.1% | -145.2% |
Quarterly
| Period | Revenue | Gross profit | Operating income | Net income | Free cash flow | Op margin | Net margin |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $1.8B | -$410M | -$2.0B | -$3.6B | — | -109.9% | -198.3% |
| 2023-12-31 | $2.8B | $1.9B | $6M | $217M | — | 0.2% | 7.7% |
| 2024-03-31 | $167M | $71M | -$1.3B | -$1.2B | -$1.2B | -758.1% | -703.6% |
| 2024-06-30 | $241M | $126M | -$1.4B | -$1.3B | — | -565.6% | -530.7% |
| 2024-09-30 | $1.9B | $1.3B | -$70M | $13M | — | -3.8% | 0.7% |
| 2024-12-31 | $966M | $227M | -$1.2B | -$1.1B | — | -129.0% | -115.9% |
| 2025-03-31 | $108M | $18M | -$1.1B | -$971M | -$1.2B | -972.2% | -899.1% |
| 2025-06-30 | $142M | $23M | -$907M | -$825M | — | -638.7% | -581.0% |
| 2025-09-30 | $1.0B | $809M | -$260M | -$200M | — | -25.6% | -19.7% |
| 2025-12-31 | $678M | $226M | -$857M | -$826M | — | -126.4% | -121.8% |
| 2026-03-31 | $389M | -$566M | -$1.4B | -$1.3B | -$692M | -356.8% | -345.2% |
| 2026-06-30 | $145M | $52M | -$815M | -$782M | — | -562.1% | -539.3% |